- 专利标题: Biguanide compositions and methods of treating metabolic disorders
-
申请号: US15339378申请日: 2016-10-31
-
公开(公告)号: US10028923B2公开(公告)日: 2018-07-24
- 发明人: Alain D. Baron , Mark S. Fineman , Nigel R. A. Beeley
- 申请人: Elcelyx Therapeutics, Inc.
- 申请人地址: US CA San Diego
- 专利权人: ELCELYX THERAPEUTICS, INC.
- 当前专利权人: ELCELYX THERAPEUTICS, INC.
- 当前专利权人地址: US CA San Diego
- 代理商 Todd A. Lorenz
- 主分类号: A61P3/10
- IPC分类号: A61P3/10 ; C07C279/26 ; A61K9/22 ; A61K31/155 ; A61K45/06 ; A61K31/55 ; A61K31/137 ; A61K31/357 ; A61K31/485 ; A61K9/20 ; A61K9/00
摘要:
Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
公开/授权文献
信息查询